AGRX

Agile Therapeutics
AGRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

62 hedge funds and large institutions have $133M invested in Agile Therapeutics in 2016 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
62
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.99M
2
+$1.14M
3
+$844K
4
PVI
Pura Vida Investments
New York
+$801K
5
HCMT
Highland Capital Management (Texas)
Texas
+$676K

Top Sellers

1
-$2.88M
2
-$2.69M
3
-$2.04M
4
GIM
Granahan Investment Management
Massachusetts
-$1.54M
5
JGC
J. Goldman & Co
New York
-$843K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$365K
27
$361K
28
$308K
29
$264K
30
$260K
31
$238K
32
$228K
33
$223K
34
$205K
35
$176K
36
$175K
37
$158K
38
$158K
39
$156K
40
$121K
41
$111K
42
$106K
43
$85K
44
$77K
45
$57K
46
$57K
47
$54K
48
$53K
49
$45K
50
$44K
1
2
3